Literature DB >> 7877993

Apoptosis and interleukin 7 gene expression in chronic B-lymphocytic leukemia cells.

B W Long1, P L Witte, G N Abraham, S A Gregory, J M Plate.   

Abstract

mRNA for interleukin 7 (IL-7) was readily detected in leukemic cells immediately upon their removal from patients with chronic B-lymphocytic leukemia (B-CLL). IL-7 mRNA expression and IL-7 gene transcription were down regulated, however, when B-CLL cells were placed in culture at 37 degrees C for 4 hr. Down regulation of the IL-7 gene was prevented in cells maintained at 4 degrees C. Continued culture of B-CLL cells at 37 degrees C resulted in programmed cell death, or apoptosis, as evidenced by DNA fragmentation. The coincident kinetics of IL-7 gene down regulation and apoptosis suggested that IL-7 gene expression may be required for maintenance of CLL viability in vivo. Signals for IL-7 gene regulation and apoptosis induction were thus examined. Activation of normal B cells through their immunoglobulin receptors did not result in upregulation of IL-7 gene expression. Reagents required for CLL cell purification and culture also did not contribute to IL-7 gene regulation and apoptosis induction. IL-7 gene expression was retained and apoptosis was prevented, however, in CLL cells cultured on a monolayer of EA.hy926 human umbilical cord endothelial hybrid cells. Signals specifically presented by EA.hy926 cells supported both CLL cell viability and IL-7 gene expression, whereas culture of CLL cells on A549/8 carcinoma cells, the fusion partner used to generate the EA.hy926 cells, did not. Cell-cell contact was required, as culture supernatants did not prevent apoptosis. Specifically, IL-7 mRNA expression was retained and apoptosis was prevented only by contact with the endothelial cell hybrids. Preliminary data indicated that integrins expressed on CLL cells affected modulation of apoptosis and IL-7 gene regulation, suggesting that integrins may play significant roles in regulating viability of CLL cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7877993      PMCID: PMC42530          DOI: 10.1073/pnas.92.5.1416

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro.

Authors:  R J Collins; L A Verschuer; B V Harmon; R L Prentice; J H Pope; J F Kerr
Journal:  Br J Haematol       Date:  1989-03       Impact factor: 6.998

2.  High serum levels of soluble interleukin 2 receptor in patients with B chronic lymphocytic leukemia.

Authors:  G Semenzato; R Foa; C Agostini; R Zambello; L Trentin; F Vinante; F Benedetti; M Chilosi; G Pizzolo
Journal:  Blood       Date:  1987-08       Impact factor: 22.113

Review 3.  Anchorage dependence, integrins, and apoptosis.

Authors:  E Ruoslahti; J C Reed
Journal:  Cell       Date:  1994-05-20       Impact factor: 41.582

4.  Permanent cell line expressing human factor VIII-related antigen established by hybridization.

Authors:  C J Edgell; C C McDonald; J B Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

Review 5.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

6.  Normal and aberrant expression of cytokines in neoplastic cells from chronic lymphocytic leukemias.

Authors:  J M Plate; W H Knospe; J E Harris; S A Gregory
Journal:  Hum Immunol       Date:  1993-04       Impact factor: 2.850

7.  The malignant B cells from B-chronic lymphocytic leukemia patients release TAC-soluble interleukin-2 receptors.

Authors:  N E Kay; J Burton; D Wagner; D L Nelson
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

8.  Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells.

Authors:  R G Goodwin; S Lupton; A Schmierer; K J Hjerrild; R Jerzy; W Clevenger; S Gillis; D Cosman; A E Namen
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

9.  Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.

Authors:  Z M Sthoeger; M Wakai; D B Tse; V P Vinciguerra; S L Allen; D R Budman; S M Lichtman; P Schulman; L R Weiselberg; N Chiorazzi
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

10.  Phosphatidyl choline is recognized by a series of Ly-1+ murine B cell lymphomas specific for erythrocyte membranes.

Authors:  T J Mercolino; L W Arnold; G Haughton
Journal:  J Exp Med       Date:  1986-01-01       Impact factor: 14.307

View more
  10 in total

1.  Cross-talk between chronic lymphocytic leukemia cells and bone marrow endothelial cells: role of signal transducer and activator of transcription 3.

Authors:  Xavier Badoux; Carlos Bueso-Ramos; David Harris; Ping Li; Zhiming Liu; Jan Burger; Susan O'Brien; Alessandra Ferrajoli; Michael J Keating; Zeev Estrov
Journal:  Hum Pathol       Date:  2011-07-05       Impact factor: 3.466

2.  Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells.

Authors:  K P Piper; M Karanth; A McLarnon; E Kalk; N Khan; J Murray; G Pratt; P A H Moss
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

3.  Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.

Authors:  Rossana Maffei; Stefania Fiorcari; Jenny Bulgarelli; Silvia Martinelli; Ilaria Castelli; Silvia Deaglio; Giulia Debbia; Marcella Fontana; Valeria Coluccio; Goretta Bonacorsi; Patrizia Zucchini; Franco Narni; Giuseppe Torelli; Mario Luppi; Roberto Marasca
Journal:  Haematologica       Date:  2011-12-29       Impact factor: 9.941

4.  Adhesion to fibronectin via alpha4 integrin (CD49d) protects B cells from apoptosis induced by serum deprivation but not via IgM or Fas/Apo-1 receptors.

Authors:  M Garcia-Gila; E M Lopez-Martin; A Garcia-Pardo
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

5.  Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy.

Authors:  A H Nwabo Kamdje; G Bassi; L Pacelli; G Malpeli; E Amati; I Nichele; G Pizzolo; M Krampera
Journal:  Blood Cancer J       Date:  2012-05-25       Impact factor: 11.037

6.  IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor.

Authors:  Ilaria Roato; Giacomina Brunetti; Eva Gorassini; Maria Grano; Silvia Colucci; Lisa Bonello; Lucio Buffoni; Roberto Manfredi; Enrico Ruffini; Davide Ottaviani; Libero Ciuffreda; Antonio Mussa; Riccardo Ferracini
Journal:  PLoS One       Date:  2006-12-27       Impact factor: 3.240

7.  A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia.

Authors:  Neil E Kay; Paolo Strati; Betsy R LaPlant; Jose F Leis; Daniel Nikcevich; Timothy G Call; Adam M Pettinger; Connie E Lesnick; Curtis A Hanson; Tait D Shanafelt
Journal:  Oncotarget       Date:  2016-11-29

8.  EphrinA4 plays a critical role in α4 and αL mediated survival of human CLL cells during extravasation.

Authors:  Miguel A Flores; Paula Fortea; Eva M Trinidad; Dolores García; Gloria Soler; Francisco J Ortuño; Agustín G Zapata; Luis M Alonso-Colmenar
Journal:  Oncotarget       Date:  2016-07-26

Review 9.  IL-7R-mediated signaling in T-cell acute lymphoblastic leukemia: An update.

Authors:  Mariana L Oliveira; Padma Akkapeddi; Daniel Ribeiro; Alice Melão; João T Barata
Journal:  Adv Biol Regul       Date:  2018-09-19

Review 10.  Targeting Receptors on Cancer Cells with Protein Toxins.

Authors:  Antonella Antignani; Eric Chun Hei Ho; Maria Teresa Bilotta; Rong Qiu; Robert Sarnvosky; David J FitzGerald
Journal:  Biomolecules       Date:  2020-09-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.